Journal ArticleDOI
Clinical epigenetics: seizing opportunities for translation.
María Berdasco,Manel Esteller +1 more
TLDR
Beyond helping to understand disease biology, clinical epigenetics is being incorporated into patient management in oncology, as well as being explored for clinical applicability for other human pathologies such as neurological and infectious diseases and immune system disorders.Abstract:
Biomarker discovery and validation are necessary for improving the prediction of clinical outcomes and patient monitoring. Despite considerable interest in biomarker discovery and development, improvements in the range and quality of biomarkers are still needed. The main challenge is how to integrate preclinical data to obtain a reliable biomarker that can be measured with acceptable costs in routine clinical practice. Epigenetic alterations are already being incorporated as valuable candidates in the biomarker field. Furthermore, their reversible nature offers a promising opportunity to ameliorate disease symptoms by using epigenetic-based therapy. Thus, beyond helping to understand disease biology, clinical epigenetics is being incorporated into patient management in oncology, as well as being explored for clinical applicability for other human pathologies such as neurological and infectious diseases and immune system disorders.read more
Citations
More filters
Integrative analysis of 111 reference human epigenomes
Anshul Kundaje,Wouter Meuleman,Jason Ernst,Angela Yen,Pouya Kheradpour,Zhizhuo Zhang,Jianrong Wang,Lucas D. Ward,Abhishek Sarkar,Gerald Quon,Matthew L. Eaton,Yi-Chieh Wu,Andreas R. Pfenning,Xinchen Wang,Melina Claussnitzer,Yaping Liu,Mukul S. Bansal,Soheil Feizi-Khankandi,Ah Ram Kim,Richard C Sallari,Nicholas A Sinnott-Armstrong,Laurie A. Boyer,Elizabeta Gjoneska,Li-Huei Tsai,Manolis Kellis +24 more
TL;DR: In this article, the authors describe the integrative analysis of 111 reference human epigenomes generated as part of the NIH Roadmap Epigenomics Consortium, profiled for histone modification patterns, DNA accessibility, DNA methylation and RNA expression.
Journal ArticleDOI
The Timeline of Epigenetic Drug Discovery: From Reality to Dreams
TL;DR: The timeline of epigenetic drug discovery and development is described, beginning with the early design based solely on phenotypic observations to the state-of-the-art rational epigenetics drug discovery using validated targets.
Journal ArticleDOI
Epigenetics in cancer therapy and nanomedicine.
TL;DR: The importance of the epigenetic alterations identified in human cancer, which have led to the appearance of biomarkers or epigenetic drugs in precision medicine, are summarized, and the transport and release systems of theigenetic drugs that have been developed to date are described.
Journal ArticleDOI
DNA Methylation Biomarkers in Aging and Age-Related Diseases.
TL;DR: This review will summarize key advances in epigenetic clocks and their potential application in precision health, and highlight the importance of prospective study designs to identify and confirm epigenetic biomarkers of disease.
Journal ArticleDOI
The Contribution of Epigenetics to Cancer Immunotherapy
TL;DR: A comprehensive up-to-date view of potential epigenetic biomarkers in immunotherapy is presented and their advantages over other indicators are discussed.
References
More filters
Journal ArticleDOI
Epigenetics and allergy: from basic mechanisms to clinical applications
Daniel P. Potaczek,Hani Harb,Hani Harb,Sven Michel,Bilal Alashkar Alhamwe,Harald Renz,Harald Renz,Jörg Tost +7 more
TL;DR: The potential of epigenetic changes for various clinical applications is shown: as diagnostic tools, to assess tolerance following immunotherapy or possibly predict the success of therapy at an early time point and new technological advances such as epigenome editing and DNAzymes will allow targeted alterations of the epigenome in the future and provide novel therapeutic tools.
Journal ArticleDOI
Effects of short-term high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men
Stine Jacobsen,Charlotte Brøns,Charlotte Brøns,Jette Bork-Jensen,Jette Bork-Jensen,Rasmus Ribel-Madsen,Beatrice T. Yang,Ester Lara,Elin Hall,Vincenzo Calvanese,E. Nilsson,Steffen Jørgensen,Steffen Jørgensen,Susanne Mandrup,Charlotte Ling,Agustín F. Fernández,Mario F. Fraga,Pernille Poulsen,Allan Vaag,Allan Vaag +19 more
TL;DR: The genome-wide DNA methylation changes induced by the short-term HFO diet could have implications for the understanding of transient epigenetic regulation in humans and its contribution to the development of metabolic diseases.
Journal ArticleDOI
Amyotrophic lateral sclerosis: Mechanisms and therapeutics in the epigenomic era
Ximena Paez-Colasante,Claudia Figueroa-Romero,Stacey A. Sakowski,Stephen A. Goutman,Eva L. Feldman +4 more
TL;DR: Understanding the molecular processes that lead to epigenetic dysregulation in patients with ALS might facilitate the discovery of novel therapeutic targets and biomarkers that could reduce diagnostic delay.
Journal ArticleDOI
Clinical use of circulating nucleosomes
TL;DR: The clinical value of nucleosomes in the diagnosis, staging, prognosis, and monitoring of therapy in cancer is described and their potential as a new diagnostic tool for the early estimation of response to cytotoxic cancer therapy is emphasized.
Journal ArticleDOI
Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory
Nitai C. Hait,Laura E. Wise,Jeremy C. Allegood,Megan A. O’Brien,Dorit Avni,Thomas M. Reeves,Pamela E. Knapp,Junyan Lu,Cheng Luo,Michael F. Miles,Sheldon Milstien,Aron H. Lichtman,Sarah Spiegel +12 more
TL;DR: It is shown that FTY 720 enters the nucleus, where it is phosphorylated by sphingosine kinase 2 (SphK2), and that nuclear FTY720-P binds and inhibits class I histone deacetylases (HDACs), enhancing specific histone acetylations.